A calming supplement developed by listening to the people who actually needed it.
How PMG worked with a wellness brand to develop a non-melatonin calming gummy from consumer research to manufacturing — and how that first product became the anchor of a growing functional supplement line.
A real consumer problem, a weak market response.
Our client had access that most supplement brands don't: a direct, ongoing relationship with a community of parents and educators working with neurodivergent children. That community had a clear, consistent, underserved need — a calming supplement for children that was effective enough to be useful, clean enough to be trusted by parents reading every label, and in a format that children would actually consume.
The existing market response was dominated by melatonin gummies — products designed to induce drowsiness rather than support calm focus. That product/need mismatch was visible in consumer behavior: parents using melatonin for situations where drowsiness was not what they needed.
The brief: develop a non-melatonin calming supplement in a kid-friendly gummy format, using ingredients with evidence behind them, with claims that were defensible under FTC and FDA (Food and Drug Administration) regulations, in a product that didn't taste medicinal.
Calm without sedation, in a technically demanding format.
The ingredient selection challenge was finding actives with evidence supporting calm and focus — rather than sleep induction — that were appropriate for the age range, available in the necessary forms and concentrations, and compatible in a gummy matrix.
We settled on a multi-active stack combining L-theanine (well-studied for calm focus, GRAS-status), magnesium glycinate (bioavailable form of magnesium with evidence for nervous system support), specific B vitamins in active forms, and a botanical component. Each ingredient had to be evaluated for: evidence quality for the target claim, regulatory status for the age range, compatibility in gummy manufacturing, flavor impact, and stability in the gummy matrix over a 24-month shelf life.
Gummies are technically harder than capsules or tablets. Getting a multi-active formula to survive the gummy manufacturing process — heat, humidity, shear forces — while maintaining potency and texture requires specific manufacturing expertise.
The line between defensible and regulatory exposure.
Structure-function claims for supplements require that they be truthful and not misleading, substantiated by competent and reliable scientific evidence, and accompanied by the required FDA disclaimer. The line between "supports calm focus" (defensible structure-function claim) and "treats anxiety" (drug claim) is exactly where supplement brands get into trouble.
Our regulatory team worked through the claims language with the client, reviewing each proposed claim against FDA guidance, FTC advertising standards, and the ingredient evidence base. The final positioning — supported by the ingredient evidence, defensible under both FDA and FTC frameworks, and aligned with how the target consumer described what they needed — was substantively different from the first draft.
A strong first product and a line extension the market asked for.
The calm focus gummy launched in DTC and specialty natural retail channels. Consumer feedback surfaced a consistent secondary request: an energy-focused variant that supported focus and energy during the day without the spike-and-crash pattern of caffeine-based products.
PMG developed the energy and focus SKU using a non-stimulant formulation — B-vitamin complex in active forms, adaptogenic botanicals, and targeted amino acids — while maintaining the same gummy format, flavor profile, and clean-label standard.
The brand now operates as a multi-SKU functional gummy line across calm focus, energy and focus, and additional formats in development.
What this case study demonstrates about PMG's capabilities.
- Consumer-grounded product development methodology — translating real user research into manufacturable products
- Gummy manufacturing expertise — technically demanding format done well
- Regulatory navigation in claim-sensitive categories — the line between defensible and exposure
- Line extension from market feedback — product roadmap development from consumer response